Melese Muluken, Chidambaram Jaya Devi, Alemayehu Wondu, Lee David Chung, Yi Elizabeth H, Cevallos Vicky, Zhou Zhaoxia, Donnellan Cathy, Saidel Michael, Whitcher John P, Gaynor Bruce D, Lietman Thomas M
ORBIS International, Addis Ababa, Ethiopia.
JAMA. 2004 Aug 11;292(6):721-5. doi: 10.1001/jama.292.6.721.
Mass antibiotic administrations for ocular chlamydial infection play a key role in the World Health Organization's trachoma control program. Mathematical models suggest that it is possible to eliminate trachoma locally with repeat mass treatment, depending on the coverage level of the population, frequency of mass treatments, and rate that infection returns into a community after each mass treatment. Precise estimates of this latter parameter have never been reported.
To determine the rate at which chlamydial infection returns to a population after mass treatment and to estimate the treatment frequency required for elimination of ocular chlamydia from a community.
DESIGN, SETTING, AND PARTICIPANTS: Longitudinal cohort study of 24 randomly selected villages from the Gurage Zone in Ethiopia conducted February 2003 to October 2003. A total of 1332 children aged 1 to 5 years were monitored for prevalence of ocular chlamydial infection pretreatment and 2 and 6 months posttreatment.
All individuals older than 1 year were eligible for single-dose oral azithromycin treatment. Pregnant women were offered tetracycline eye ointment.
Prevalence of ocular chlamydial infection, measured by polymerase chain reaction, in children aged 1 to 5 years, in each of 24 villages at each time point was used to estimate the rate of return of infection and the treatment frequency necessary for elimination.
The prevalence of infection was 56.3% pretreatment (95% confidence interval [CI], 47.5%-65.1%), 6.7% 2 months posttreatment (95% CI, 4.2%-9.2%), and 11.0% 6 months posttreatment (95% CI, 7.3%-14.7%). Infection returned after treatment at an exponential rate of 12.3% per month (95% CI, 4.6%-19.9% per month). The minimum treatment frequency necessary for elimination was calculated to be once every 11.6 months (95% CI, 7.2-30.9 months), given a coverage level of 80%. Thus, biannual treatment, already being performed in some areas, was estimated to be more than frequent enough to eventually eliminate infection.
The rate at which ocular chlamydial infection returns to a community after mass treatment suggests that elimination of infection in a hyperendemic area is feasible with biannual mass antibiotic administrations and attainable coverage levels.
大规模抗生素治疗眼部衣原体感染在世界卫生组织的沙眼控制项目中发挥着关键作用。数学模型表明,根据人群覆盖水平、大规模治疗频率以及每次大规模治疗后感染重新进入社区的速率,通过重复大规模治疗有可能在局部消除沙眼。但从未有关于后一参数的精确估计报告。
确定大规模治疗后衣原体感染重新回到人群的速率,并估计从社区消除眼部衣原体所需的治疗频率。
设计、地点和参与者:2003年2月至2003年10月在埃塞俄比亚古拉格地区随机选择的24个村庄进行的纵向队列研究。对1332名1至5岁儿童在治疗前以及治疗后2个月和6个月时的眼部衣原体感染患病率进行监测。
所有1岁以上个体均有资格接受单剂量口服阿奇霉素治疗。为孕妇提供四环素眼膏。
通过聚合酶链反应测量的1至5岁儿童眼部衣原体感染患病率,在每个时间点的24个村庄中分别用于估计感染复发率和消除感染所需的治疗频率。
治疗前感染患病率为56.3%(95%置信区间[CI],47.5%-65.1%),治疗后2个月为6.7%(95%CI,4.2%-9.2%),治疗后6个月为11.0%(95%CI,7.3%-14.7%)。治疗后感染以每月12.3%的指数速率复发(95%CI,每月4.6%-19.9%)。在80%的覆盖水平下,消除感染所需的最低治疗频率经计算为每11.6个月一次(95%CI,7.2-30.9个月)。因此,一些地区已经在进行的半年一次治疗估计频率足够高,最终足以消除感染。
大规模治疗后眼部衣原体感染回到社区的速率表明,在高度流行地区通过半年一次的大规模抗生素给药和可达到的覆盖水平消除感染是可行的。